Benitec Biopharma (BNTC) Other Gross PP&E Adjustments (2019 - 2025)
Benitec Biopharma has reported Other Gross PP&E Adjustments over the past 7 years, most recently at $589000.0 for Q4 2025.
- Quarterly results put Other Gross PP&E Adjustments at $589000.0 for Q4 2025, down 55.07% from a year ago — trailing twelve months through Dec 2025 was $589000.0 (down 55.07% YoY), and the annual figure for FY2025 was $385000.0, down 62.91%.
- Other Gross PP&E Adjustments reached $589000.0 in Q4 2025 per BNTC's latest filing, down from $814000.0 in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $1.3 million in Q4 2024 and bottomed at $385000.0 in Q2 2025.
- Median Other Gross PP&E Adjustments over the past 5 years was $627500.0 (2022), compared with a mean of $725400.0.
- The largest annual shift saw Other Gross PP&E Adjustments tumbled 66.87% in 2022 before it soared 66.77% in 2024.
- Over 5 years, Other Gross PP&E Adjustments stood at $408000.0 in 2021, then soared by 53.92% to $628000.0 in 2022, then skyrocketed by 38.38% to $869000.0 in 2023, then skyrocketed by 50.86% to $1.3 million in 2024, then plummeted by 55.07% to $589000.0 in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for BNTC at $589000.0 in Q4 2025, $814000.0 in Q3 2025, and $385000.0 in Q2 2025.